欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号ES/V/0388/001
药品名称Labiprofen 150 mg/ml solution for injection
活性成分
    • KETOPROFEN 150.0 mg/ml
剂型Solution for injection
上市许可持有人LABIANA Life Sciences, S.A. Can Parellada Industrial Calle Venus, 26 08228 Terrassa (Barcelona) Spain
参考成员国 - 产品名称Spain (ES)
Labiprofen 150 mg/ml solución inyectable para bovino, porcino y caballos
互认成员国 - 产品名称
    • Ireland (IE)
    • Belgium (BE)
      Labiprofen 150 mg/ml
    • Denmark (DK)
    • United Kingdom (Northern Ireland) (XI)
    • Portugal (PT)
    • Luxembourg (LU)
    • Latvia (LV)
      Labiprofen 150 mg/ml šķīdums injekcijām liellopiem, cūkām un zirgiem
    • Romania (RO)
    • Germany (DE)
    • Austria (AT)
    • Lithuania (LT)
    • Estonia (EE)
    • Sweden (SE)
    • Hungary (HU)
    • Finland (FI)
    • Bulgaria (BG)
    • Norway (NO)
    • Slovenia (SI)
    • France (FR)
      LABIPROFEN 150 MG/ML SOLUTION INJECTABLE POUR BOVINS, PORCINS ET CHEVAUX
    • Croatia (HR)
    • Italy (IT)
    • Greece (GR)
许可日期2020/12/16
最近更新日期2025/05/09
药物ATC编码
    • QM01AE03 ketoprofen
申请类型
  • TypeLevel1：food
  • TypeLevel2：Pharmaceutical
  • TypeLevel3：Generic - art 13.2 Dir 2001/82/EC
  • TypeLevel4：[not specified]
  • TypeLevel5：[not specified]
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase